These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4740130)

  • 21. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
    Marazzi-Uberti E; Bianchi C; Gaetani M; Pozzi L
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in painful osteoarticular conditions.
    Pasotti C; Barbieri C; Buniva G; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:262-5. PubMed ID: 4553234
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. Enzyme induction and interaction with other drugs in the rat.
    Coppi G; Vidi A; Vanoni PC; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:242-6. PubMed ID: 4111897
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. A comparative study of short-term toxicity of DA 2370 and other non-steroid anti-inflammatory drugs (phenylbutazone, mefenamic acid, indometacin and benzydamine) in the rat.
    Gaetani M; Debeus R; Vidi A; Coppi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:226-3. PubMed ID: 5067198
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. General pharmacological properties.
    Bianchi C; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:196+. PubMed ID: 5067191
    [No Abstract]   [Full Text] [Related]  

  • 26. [Painful shoulder: treatment by 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine].
    LEITAO A
    Hospital (Rio J); 1958 Sep; 54(3):335-8. PubMed ID: 13586748
    [No Abstract]   [Full Text] [Related]  

  • 27. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Action on local and systemic chemical responses in the rat with an experimental inflammatory process.
    Coppi G; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:237+. PubMed ID: 5067200
    [No Abstract]   [Full Text] [Related]  

  • 28. [Contribution to the pharmacodynamic study of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidinopiperazine].
    La Barre J; Derouaux G; Oleffe-Koopmansch S
    Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):265-83. PubMed ID: 5954030
    [No Abstract]   [Full Text] [Related]  

  • 29. [About the glucoside of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine (phenylbutazone)].
    MOREL CJ
    Experientia; 1958 Aug; 14(8):294-5. PubMed ID: 13574145
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thin-layer chromatography of 1-phenyl-4n-butyl-3,5-dioxopyrazolidine (Monophenylbutazone)].
    Salzmann U
    Pharm Acta Helv; 1971 Dec; 46(12):721-9. PubMed ID: 5143003
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine on phosphatases. 2].
    OHLMEYER P; KROMER H
    Arzneimittelforschung; 1958 Apr; 8(4):247-8. PubMed ID: 13535368
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine on phosphatases].
    HAHN E; PLATE B
    Arzneimittelforschung; 1956 Dec; 6(12):728-9. PubMed ID: 13395936
    [No Abstract]   [Full Text] [Related]  

  • 33. Microbiological transformation of 1,2-diphenyl-3,5 dioxo-4-n-butyl pyrazolidine (phenylbutazone).
    Favero J; Winternitz F
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):1-7. PubMed ID: 7389746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine (butazolidine) on cortisone metabolism in rat liver].
    DIRSCHERL W; KORUS W; SCHRIEFERS H
    Arzneimittelforschung; 1956 Oct; 6(10):596-8. PubMed ID: 13373678
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thin layer chromatography of derivatives of pyrazolone].
    Sarsúnová M; Kakác B
    Pharmazie; 1972 Jul; 27(7):447-8. PubMed ID: 5087238
    [No Abstract]   [Full Text] [Related]  

  • 36. Absorption and distribution of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA2370) in the rat.
    Coppi G; Vidi A; Gallazzi A; Perego R
    Arzneimittelforschung; 1974 May; 24(5):801-2. PubMed ID: 4408147
    [No Abstract]   [Full Text] [Related]  

  • 37. Structure-activity relationships in anti-inflammatory compounds chemically related to 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Pala G; Mantegani A; Donetti A; Lumachi B; Marazzi-Uberti E; Casadio S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:174-7. PubMed ID: 5067188
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacological studies of 2-diphenyl-r4-(gamma-ketobutyl)-pyrazolidine-3, 5-dione].
    Kameyama T; Oyanagi K; Magao S; Yamada T
    Nihon Yakurigaku Zasshi; 1968 Mar; 64(2):1-9. PubMed ID: 5749290
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mechanism of action of aminophenazone and 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine].
    VOELKEL A
    Arzneimittelforschung; 1956 Dec; 6(12):720-2. PubMed ID: 13395932
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oral medication of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine and thyroid function].
    KLEIN E
    Arzneimittelforschung; 1956 Dec; 6(12):726-8. PubMed ID: 13395935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.